Literature DB >> 24843312

Regression of peripapillary choroidal neovascular membrane in a patient with sarcoidosis after oral steroid therapy.

Samir S Shoughy1, Mahmoud O Jaroudi1, Khalid F Tabbara2.   

Abstract

Choroidal neovascular membrane (CNV) may occur in patients with posterior uveitis. Treatment of patients with corticosteroids induces regression of the inflammation in the posterior pole with downregulation of many cytokines including vascular endothelial growth factors. We report herewith, a case of biopsy proven sarcoidosis that developed posterior uveitis and peripapillary CNV membrane and subretinal hemorrhage with fluid. The patient was treated with systemic steroids. She demonstrated progressive regression of the CNV membrane and complete resolution of the subretinal hemorrhage and fluids. In conclusion, control of the posterior segment inflammation is crucial in the resolution of the CNV membrane in uveitis and the intravitreal anti-vascular endothelial growth factor may not be always indicated.

Entities:  

Keywords:  Oral steroids; Peripapillary CNV; Sarcoidosis

Year:  2014        PMID: 24843312      PMCID: PMC4023110          DOI: 10.1016/j.sjopt.2014.02.007

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  8 in total

Review 1.  Peripapillary subretinal neovascularization. A review.

Authors:  P F Lopez; W R Green
Journal:  Retina       Date:  1992       Impact factor: 4.256

2.  Limited long-term efficacy of intravitreous anti-VEGF pharmacotherapy in sarcoidosis complicated by peripapillary choroidal neovascular membrane.

Authors:  Sumit P Shah; Jean-Pierre Hubschman; Jean-Louis Bourges; Allen Y H Hu; Steven D Schwartz
Journal:  Acta Ophthalmol       Date:  2010-09       Impact factor: 3.761

3.  Ocular conditions associated with peripapillary subretinal neovascularization, their relative frequencies, and associated outcomes.

Authors:  David J Browning; Christina M Fraser
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

4.  Diagnostic management of patients with suspected ocular sarcoidosis.

Authors:  Kazuto Takada; Shuuichi Matsumoto; Eiji Kojima; Susumu Iwata; Kentarou Tanaka
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

5.  Peripapillary subretinal neovascularization in presumed sarcoidosis.

Authors:  E S Gragoudas; C D Regan
Journal:  Arch Ophthalmol       Date:  1981-07

6.  Peripapillary subretinal neovascularization in peripheral uveitis.

Authors:  D F Arkfeld; R J Brockhurst
Journal:  Retina       Date:  1985 Summer-Fall       Impact factor: 4.256

7.  A case of macular subretinal neovascularisation in chronic uveitis probably caused by sarcoidosis.

Authors:  H A Hoogstede; A C Copper
Journal:  Br J Ophthalmol       Date:  1982-08       Impact factor: 4.638

8.  Peripapillary choroidal neovascularization in pars planitis.

Authors:  Sonia Mehta; Luxme Hariharan; Allen C Ho; John H Kempen
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-15
  8 in total
  2 in total

1.  Clinical manifestations and outcomes of ocular sarcoidosis in Saudi Arabia.

Authors:  Samir S Shoughy; Mahmoud O Jaroudi; Khalid F Tabbara; Igor Kozak
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

2.  Prevalence of peripapillary choroidal neovascular membranes (PPCNV) in an elderly UK population-the Bridlington eye assessment project (BEAP): a cross-sectional study (2002-2006).

Authors:  Craig Wilde; Ali Poostchi; Rajnikant L Mehta; Jonathan G Hillman; Hamish K MacNab; Marco Messina; Gaspare Monaco; Stephen A Vernon; Winfried M Amoaku
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.